Evidence map›Paper›PMID 31020451›Full record

ReviewHeart failure reviews2019

Primary graft dysfunction after heart transplantation: a thorn amongst the roses.

Sanjeet Singh Avtaar Singh, Jonathan R Dalzell, Colin Berry, Nawwar Al-Attar

Open access · hybridAbstract readReview
In one paragraph

Review in Heart failure reviews, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 128 citations in OpenAlex.

  1. Differential transcriptomic and metabolomic landscape between human hearts donated after cardiac vs brain death.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Review
  7. Review
  8. Article
  9. Review
  10. Recipient plasma metabolomics as a predictor of heart transplant severe primary graft dysfunction.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  11. Article
  12. New Perfusion and Preservation Strategies for Donor Hearts.European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sanjeet Singh Avtaar SinghDepartment of Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow, Scotland. sanjeetsingh@nhs.net.ORCID http://orcid.org/0000-0003-4320-0734
Jonathan R DalzellScottish National Advanced Heart Failure Service, Golden Jubilee National Hospital, Glasgow, Scotland.
Colin BerryInstitute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, Scotland.
Nawwar Al-AttarDepartment of Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow, Scotland.
Golden Jubilee National Hospital · GBUniversity of Glasgow · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary graft dysfunction (PGD) remains the leading cause of early mortality post-heart transplantation. Despite improvements in mechanical circulatory support and critical care measures, the rate of PGD remains significant. A recent consensus statement by the International Society of Heart and Lung Transplantation (ISHLT) has formulated a definition for PGD. Five years on, we look at current concepts and future directions of PGD in the current era of transplantation.

Indexed as

BiomarkersCatecholaminesFemaleGraft RejectionHeart TransplantationHumansIncidenceMalePhosphodiesterase InhibitorsPlasmapheresisPrimary Graft DysfunctionRisk FactorsTerminology as TopicTissue DonorsTransplant RecipientsBiomarkersCatecholaminesPhosphodiesterase InhibitorsManagementPathophysiologyPreventionPrimary graft dysfunctionTreatment

Identifiers

PMID31020451
PMCPMC6697758
OpenAlexW2941268651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.